Swiss National Bank
GH icon

Swiss National Bank’s Guardant Health GH Stock Holding History

Swiss National Bank’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.5M Buy
243,500
+21,400
+10% +$2.33M 0.02% 522
2026
Q1 		$20.5M Buy
222,100
+800
+0.4% +$80.3K 0.01% 647
2025
Q4 		$22.6M Buy
221,300
+5,200
+2% +$465K 0.01% 617
2025
Q3 		$13.5M Buy
216,100
+4,000
+2% +$218K 0.01% 805
2025
Q2 		$11M Sell
212,100
-27,200
-11% -$1.21M 0.01% 868
2025
Q1 		$10.2M Sell
239,300
-2,600
-1% -$112K 0.01% 887
2024
Q4 		$7.39M Buy
241,900
+2,500
+1% +$70.3K ﹤0.01% 1094
2024
Q3 		$5.49M Hold
239,400
– – ﹤0.01% 1272
2024
Q2 		$6.91M Buy
239,400
+11,700
+5% +$272K ﹤0.01% 1080
2024
Q1 		$4.7M Buy
227,700
+7,300
+3% +$156K ﹤0.01% 1335
2023
Q4 		$5.96M Sell
220,400
-24,300
-10% -$637K ﹤0.01% 1179
2023
Q3 		$7.25M Buy
244,700
+6,500
+3% +$229K 0.01% 1059
2023
Q2 		$8.53M Buy
238,200
+28,100
+13% +$807K 0.01% 997
2023
Q1 		$4.92M Sell
210,100
-12,000
-5% -$343K ﹤0.01% 1289
2022
Q4 		$6.04M Buy
222,100
+4,600
+2% +$210K ﹤0.01% 1201
2022
Q3 		$11.7M Buy
217,500
+1,500
+0.7% +$77K 0.01% 802
2022
Q2 		$8.71M Buy
216,000
+11,700
+6% +$580K 0.01% 995
2022
Q1 		$13.5M Buy
204,300
+14,800
+8% +$1.01M 0.01% 836
2021
Q4 		$19M Sell
189,500
-400
-0.2% -$41.4K 0.01% 705
2021
Q3 		$23.7M Buy
189,900
+1,700
+0.9% +$202K 0.02% 642
2021
Q2 		$23.4M Buy
188,200
+16,900
+10% +$2.27M 0.01% 658
2021
Q1 		$26.1M Buy
171,300
+2,700
+2% +$408K 0.02% 625
2020
Q4 		$21.7M Buy
168,600
+40,000
+31% +$4.6M 0.02% 637
2020
Q3 		$14.4M Buy
128,600
+2,400
+2% +$220K 0.01% 684
2020
Q2 		$10.2M Buy
126,200
+53,300
+73% +$4.29M 0.01% 759
2020
Q1 		$5.07M Buy
72,900
+1,700
+2% +$130K 0.01% 928
2019
Q4 		$5.56M Buy
71,200
+2,600
+4% +$187K 0.01% 1081
2019
Q3 		$4.38M Buy
68,600
+36,700
+115% +$3.23M ﹤0.01% 1177
2019
Q2 		$2.75M Buy
+31,900
New +$2.44M ﹤0.01% 1503

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Swiss National Bank's GH Position: Q2 2026 in Review

Swiss National Bank increased its Guardant Health (GH) stake by 9.6% in Q2 2026, buying an estimated $2.33M and bringing the position to 243,500 shares worth $36.5M. The position accounts for 0.02% of the portfolio, ranked #522.

Swiss National Bank first reported a position in GH in Q2 2019 and has held it in 29 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Swiss National Bank held 243,500 shares of Guardant Health worth $36.5M as of Q2 2026.
  • Swiss National Bank bought 21,400 Guardant Health shares in Q2 2026, an estimated $2.33M.
  • Guardant Health made up 0.02% of Swiss National Bank's portfolio in Q2 2026, its #522 holding.
  • Swiss National Bank first reported a position in Guardant Health in Q2 2019 and has held it in 29 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.